Literature DB >> 1347528

Characterization of two site-specifically mutated human dihydrolipoamide dehydrogenases (His-452----Gln and Glu-457----Gln).

H Kim1, M S Patel.   

Abstract

Two site-specifically mutated human dihydrolipoamide dehydrogenases (His-452----Gln and Glu-457----Gln) were expressed in pyruvate dehydrogenase complex-deletion mutant Escherichia coli JRG1342. The expressed mutant E3s were purified to near homogeneity using DEAE-Sephacel and hydroxyapatite columns. The initial velocity measurements in the absence of products for the Gln-452 mutant E3 in the direction of NAD+ reduction showed parallel lines in double-reciprocal plots, indicating that the mutant E3, like wild-type enzyme, catalyzed E3 reaction via a ping-pong mechanism. The specific activity of the Gln-452 mutant E3 was about 0.2% of that of wild-type enzyme. Its Km for dihydrolipoamide was dramatically increased by 63-fold. The substitution of His-452 to Gln resulted in a destabilization of the transition state of human E3 catalysis by about 6.4 kcal mol-1. The Gln-457 mutant E3, unlike wild-type enzyme, catalyzed E3 reaction via a sequential mechanism in the direction of NAD+ reduction based on the intersecting lines shown on double-reciprocal plots. Its specific activity decreased to 28% of that of wild-type enzyme. Its Km for dihydrolipoamide increased about 4.3-fold. The substitution of Glu-457 to Gln resulted in a destabilization of the transition state by about 1.7 kcal mol-1. These results indicate that His-452, which is a possible proton acceptor/donor in human E3 reaction, is critical to human E3 catalysis and that the local environment around His-452 and Glu-457, which are suggested to be hydrogen-bonded, is important in the binding of dihydrolipoamide to the enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347528

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Mutations in the dimer interface of dihydrolipoamide dehydrogenase promote site-specific oxidative damages in yeast and human cells.

Authors:  Rachael A Vaubel; Pierre Rustin; Grazia Isaya
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Modulated Protein Binding Ability of Anti-Diabetic Drugs in Presence of Monodispersed Gold Nanoparticles and its Inhibitory Potential towards Advanced Glycated End (AGE) Product Formation.

Authors:  Imocha Rajkumar Singh; Sivaprasad Mitra
Journal:  J Fluoresc       Date:  2020-01-10       Impact factor: 2.217

3.  Targeted disruption of the murine dihydrolipoamide dehydrogenase gene (Dld) results in perigastrulation lethality.

Authors:  M T Johnson; H S Yang; T Magnuson; M S Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Purification of the pyruvate dehydrogenase multienzyme complex of Zymomonas mobilis and identification and sequence analysis of the corresponding genes.

Authors:  U Neveling; R Klasen; S Bringer-Meyer; H Sahm
Journal:  J Bacteriol       Date:  1998-03       Impact factor: 3.490

5.  Underlying molecular alterations in human dihydrolipoamide dehydrogenase deficiency revealed by structural analyses of disease-causing enzyme variants.

Authors:  Eszter Szabo; Piotr Wilk; Balint Nagy; Zsofia Zambo; David Bui; Andrzej Weichsel; Palaniappa Arjunan; Beata Torocsik; Agnes Hubert; William Furey; William R Montfort; Frank Jordan; Manfred S Weiss; Vera Adam-Vizi; Attila Ambrus
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

6.  A pH-dependent kinetic model of dihydrolipoamide dehydrogenase from multiple organisms.

Authors:  Michael A Moxley; Daniel A Beard; Jason N Bazil
Journal:  Biophys J       Date:  2014-12-16       Impact factor: 4.033

7.  Interaction of E1 and E3 components with the core proteins of the human pyruvate dehydrogenase complex.

Authors:  Mulchand S Patel; Lioubov G Korotchkina; Sukhdeep Sidhu
Journal:  J Mol Catal B Enzym       Date:  2009-11-01

8.  Structural alterations induced by ten disease-causing mutations of human dihydrolipoamide dehydrogenase analyzed by hydrogen/deuterium-exchange mass spectrometry: Implications for the structural basis of E3 deficiency.

Authors:  Attila Ambrus; Junjie Wang; Reka Mizsei; Zsofia Zambo; Beata Torocsik; Frank Jordan; Vera Adam-Vizi
Journal:  Biochim Biophys Acta       Date:  2016-08-18

9.  A new level of architectural complexity in the human pyruvate dehydrogenase complex.

Authors:  Michaela Smolle; Alison Elizabeth Prior; Audrey Elaine Brown; Alan Cooper; Olwyn Byron; John Gordon Lindsay
Journal:  J Biol Chem       Date:  2006-05-05       Impact factor: 5.157

10.  Structural alterations by five disease-causing mutations in the low-pH conformation of human dihydrolipoamide dehydrogenase (hLADH) analyzed by molecular dynamics - Implications in functional loss and modulation of reactive oxygen species generation by pathogenic hLADH forms.

Authors:  Attila Ambrus; Reka Mizsei; Vera Adam-Vizi
Journal:  Biochem Biophys Rep       Date:  2015-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.